A federal commission is calling for $15 billion in new financing to reinforce U.S. biotech leadership amid competition from ...

Republicans in Congress, long an unwavering source of support for privatized Medicare plans, are increasingly calling for ...

Those advances have economic and public health implications globally, including in the United States, Ernst said. Although ...

Pain is the most costly chronic health problem in the U.S. In latest RIFs at NIH, an entire division devoted to pain research ...

President Trump’s Medicare agency finalized a rule Monday that would raise benchmark payment rates to privatized Medicare ...

Health insurers in the Medicare Advantage business have a big incentive to diagnose their members with lots of health ...

From my colleague Allison DeAngelis: Over the last few years, the drug industry has rushed to retool CAR-T treatments for ...

Bayer has asked the U.S. Supreme Court to decide whether federal law preempts thousands of state lawsuits alleging it failed ...

Democrats in Congress have long pressed for an overhaul of the $500 billion Medicare Advantage program. On the other side of ...

Health secretary RFK Jr. told the AP Monday that he will tell the CDC soon to stop recommending fluoridation in communities ...

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...

The government already struggles to find licensees for many of its inventions, and adding more red tape in the form of the ...